REAP Financial Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

REAP Financial Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Sell	936 -18	-2%	-$3.88K	0.04%	121
2026 Q1	$192K	Sell	954 -23	-2%	-$4.76K	0.04%	133
2025 Q4	$202K	Sell	977 -136	-12%	-$27.2K	0.04%	126
2025 Q3	$200K	Buy	1,113 +133	+14%	+$22.6K	0.04%	113
2025 Q2	$158K	Hold	980	–	–	0.04%	132
2025 Q1	$167K	Hold	980	–	–	0.04%	110
2024 Q4	$163K	Buy	980 +400	+69%	+$68.3K	0.04%	123
2024 Q3	$99.7K	Sell	580 -379	-40%	-$62.7K	0.02%	159
2024 Q2	$148K	Sell	959 -442	-32%	-$66.3K	0.04%	135
2024 Q1	$215K	Sell	1,401 -21	-1%	-$3.2K	0.06%	120
2023 Q4	$225K	Buy	+1,422	New	+$204K	0.07%	126

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

REAP Financial Group's FBT Position: Q2 2026 in Review

REAP Financial Group reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1.9% in Q2 2026, selling an estimated $3.88K and leaving 936 shares worth $232K. The position accounts for 0.04% of the portfolio, ranked #121.

REAP Financial Group first reported a position in FBT in Q4 2023 and has held it in 11 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

REAP Financial Group held 936 shares of First Trust NYSE Arca Biotechnology Index Fund worth $232K as of Q2 2026.
REAP Financial Group sold 18 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $3.88K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.04% of REAP Financial Group's portfolio in Q2 2026, its #121 holding.
REAP Financial Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 11 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.